Related Experiment Video
Updated: Jul 25, 2025

Detection of Polyfunctional T Cells in Children Vaccinated with Japanese Encephalitis Vaccine via the Flow Cytometry Technique
Published on: September 23, 2022
Kawasaki disease (KD) and multisystem inflammatory syndrome in children (MIS-C) in a Middle Eastern patient cohort
Lemis Yavuz1,2, Sarmad AlHamdani3, Samah Alasrawi4
1Al Jalila General Pediatric Department, Al Jalila Children's Hospital, Dubai, United Arab Emirates. osmanlames@hotmail.com.
Insights
Kawasaki disease (KD) and Multi-system Inflammatory Syndrome in Children (MIS-C) share similarities but have distinct features. This study developed a formula to differentiate between KD and MIS-C, suggesting MIS-C may be a severe variant of KD.
Area of Science:
- Pediatrics
- Infectious Diseases
- Immunology
Background:
- Kawasaki disease (KD) and Multi-system Inflammatory Syndrome in Children (MIS-C) are pediatric inflammatory conditions with overlapping clinical presentations.
- Differentiating between KD and MIS-C is crucial for appropriate management and understanding disease spectrums.
Purpose of the Study:
- To conduct a comprehensive characteristic study of KD and MIS-C in the Middle East.
- To develop a formula for differentiating between KD and MIS-C based on clinical and laboratory findings.
Main Methods:
- A descriptive comparative study was conducted in the United Arab Emirates.
- Retrospective cohorts of KD and MIS-C patients (January 2017-August 2021) were analyzed.
- Clinical and laboratory data were compared between groups and with literature data.
Main Results:
- 123 patients were analyzed: 67 with KD and 56 with MIS-C.
- MIS-C patients were older (median 7.3 years vs. 2.2 years for KD) and presented more gastrointestinal symptoms (84% vs. 31%).
- KD showed higher white blood cells, neutrophils, lymphocytes, ESR, and platelets, while MIS-C had elevated procalcitonin and ferritin. Cardiac dysfunction and PICU admission were higher in MIS-C.
Conclusions:
- KD and MIS-C exhibit significant similarities, suggesting they may exist on a similar clinical spectrum.
- Distinct differences indicate MIS-C could represent a severe variant of KD.
- A novel formula was developed to aid in differentiating between KD and MIS-C.
Objective:
This is a comprehensive characteristic study of Kawasaki disease (KD) and Multi system inflammatory syndrome in children (MIS-C) in the Middle East that creates a formula to differentiate between the two.
Methods:
We conducted a descriptive comparative study of KD and MIS-C in the United Arab Emirates. Retrospective MIS-C and KD cohorts were recruited between January 2017 until August 2021.We compared clinical and laboratory characteristics between both groups. Our data were compared with 87 patients with KD or MIS-C from the literature.
Results:
We report on123 patients. Sixty-seven (54%) met the criteria for KD (36 male, 43 Arab), and fifty-six (46%) met the criteria for MIS-C (28 male, 35 Arab). The median age was 2.2 years range (0.15-10.7) in the KD group and 7.3 years (0.7-15.2) in the MIS-C group (P < 0.001). The clinical features on admission showed an increase in gastrointestinal manifestations in MIS-C compared with KD (84% vs. 31%, P < 0.001). Laboratory tests on admission revealed a significant increase in the following tests in KD compared with MIS-C; white blood cells (mean 16.30 10(3) µcL vs. 11.56 10(3) µcL, P < 0.001), absolute neutrophils (mean 10.72 10(3) µcL vs. 8.21 10(3) µcL, P 0.008), absolute lymphocytes (mean 3.92 10(3) µcL vs. 2.59 10(3) µcL, P 0.003), erythrocyte sedimentation rate (mean 73 mm/hr vs. 51 mm/hr, P < 0.001) and platelets (median {390 10(3) µcL vs. 236 10(3) µcL, P < 0.001}). In contrast, procalcitonin and ferritin were increased in the MIS-C group (2.4 )ng/mL, 370 ng/mL; P < 0.001). Cardiac dysfunction and admission to the pediatric intensive care unit were higher in MIS-C than in KD (21% vs. 8% and 33% vs. 7.5%, respectively, P < 0.001).
Conclusion:
This study showed vast similarities between KD and MIS-C, suggesting that they lie along the same clinical spectrum. However, there are several differences between the two disease entities suggesting that MIS-C most likely represents a new severe variant of KD. Based on our findings in this study, we created a formula to differentiate between KD and MIS-C.
Related Concept Videos
Nephrotic Syndrome II : Assessment and Medical Management
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Endocarditis II: Clinical Features of Infective Endocarditis
Acute Kidney Injury III: Clinical Manifestations
Nephrotic Syndrome I : Introduction
The JAK-STAT Signaling Pathway

